We anticipate that this will not only motivate further development of AAV and SHN3-based gene therapeutic approaches, but moreover provide evidence for marked disruption in the vascular and SSC compartments as a feature of OI that could be central to disease pathogenesis. This evidence concerns the gene HIVEP3 and osteogenesis imperfecta.